Risk of Hepatitis B Reactivation in Patients Receiving Ibrutinib: The National Veterans Affairs CohortOPEN FORUM INFECTIOUS DISEASESIF3.82024-01-100OA
FDrisk: Development of a validated risk assessment tool for Fabry disease utilizing electronic health record dataMOLECULAR GENETICS AND METABOLISMIF3.52023-02-010PRE
Provider Attitudes Toward Risk-Based Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis in the United StatesCLINICAL GASTROENTEROLOGY AND HEPATOLOGYIF122022-01-0117OAAI
The COVID-19 Pandemic Highlights Opportunities to Improve Hepatocellular Carcinoma Screening and Diagnosis in a National Health SystemAMERICAN JOURNAL OF GASTROENTEROLOGYIF7.62021-12-2916OA
Hemoadsorption in 'Liver Indication'-Analysis of 109 Patients' Data from the CytoSorb International RegistryJOURNAL OF CLINICAL MEDICINEIF2.92021-11-0529OAAI
Rates and Predictors of Undergoing Different Hepatocellular Carcinoma Screening Tests in Patients With CirrhosisAMERICAN JOURNAL OF GASTROENTEROLOGYIF7.62020-11-268PRE
Etoposide Catechol Is an Oxidizable Topoisomerase II PoisonCHEMICAL RESEARCH IN TOXICOLOGYIF3.82013-07-2323PREAI
Comparative validation of manual and automated methods for mixing and volume control in whole blood collectionTRANSFUSION CLINIQUE ET BIOLOGIQUEIF1.21997-07-013PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向